PT  - JOURNAL ARTICLE
AU  - Pearl Anne Ante-Testard
AU  - Mohamed Hamidouche
AU  - Bénédicte Apouey
AU  - Rachel Baggaley
AU  - Joseph Larmarange
AU  - Tarik Benmarhnia
AU  - Laura Temime
AU  - Kévin Jean
TI  - Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries: a mediation analysis
AID  - 10.1101/2021.09.18.21263768
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.18.21263768
4099  - http://medrxiv.org/content/early/2021/09/22/2021.09.18.21263768.short
4100  - http://medrxiv.org/content/early/2021/09/22/2021.09.18.21263768.full
AB  - Introduction Although socioeconomic inequalities in HIV prevention, testing and treatment services have been well documented, their drivers remain poorly understood. Understanding the different pathways between socioeconomic position and HIV testing across different countries could help designing tailored programs aimed at reducing such inequalities.Methods We analysed data from Demographic and Health Surveys conducted between 2010 and 2018 in 18 sub-Saharan African countries (Burkina Faso, Cameroon, Côte d’Ivoire, Congo DR, Ethiopia, Guinea, Kenya, Lesotho, Liberia, Malawi, Mali, Niger, Rwanda, Senegal, Sierra Leone, Tanzania, Zambia and Zimbabwe). Using a potential outcomes framework and the product method, we decomposed the total effect linking wealth and recent (< 12 months) HIV testing into i) direct effects, and ii) indirect effects, via demand-related (related to individual’s ability to perceive need for care and inclination to seek care) or supply-related (related to individual’s ability to reach, pay for and engage in health care) mediators. Multivariable gender-specific modified Poisson models were fitted to estimate proportions mediated, while accounting for exposure-mediator interaction when present.Results A total of 392,044 participants were included in the analysis. Pro-rich wealth-related inequalities were observed in a majority of countries, with nine countries with high levels of inequalities among women and 15 countries among men.The indirect effects of each mediator varied greatly across countries. The proportion mediated tended to be higher for demand-related than for supply-related mediators. For instance, among women, HIV-related knowledge was estimated to mediate up to 12.1% of inequalities in Côte d’Ivoire; this proportion was up to 31.5% for positive attitudes toward people living with HIV (PLHIV) in Senegal. For the four supply-related mediators, the proportion mediated was systematically below 7%. Similar conclusions were found when repeating analyses on men for the demand-related mediators, with higher proportions mediated by positive attitudes toward PLHIV (up to 39.9% in Senegal).Conclusions Our findings suggest that socioeconomic inequalities in HIV testing may be mediated by the demand-side more than supply-side characteristics, with important variability across countries. Overall, the important inter-country heterogeneity in pathways of socioeconomic inequalities in HIV testing illustrates that addressing inequalities requires tailored efforts as well as upstream interventions.A French version of the abstract is available upon request from the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by INSERM-ANRS (France Recherche Nord and Sud Sida-HIV Hepatites), grant number ANRS 12377-B104. Disclaimer: Funding agency had no role in the study design, data collection and analysis.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The national implementing agencies or research institutes that conducted the surveys were responsible for ethical clearance which assured informed consent from the participants prior to their involvement and guaranteed confidentiality of information.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data from the DHS surveys used in this study are publicly available for academic research (www.dhsprogram.com). Formatted and processed data supporting the findings of this study are available from the corresponding author on request. https://www.dhsprogram.com